Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Queen

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Psychological Medicine|April 5, 2013
Under-reporting of drug use among individuals with schizophrenia: prevalence and predictorsA L Bahorik, C E Newhill, C C Queen, et al.
Psychological Medicine|February 14, 2014
Letter to the editor: Critique of Bahorik et al. (2013)--'Underreporting of drug use among individuals with schizophrenia: prevalence and predictors'--a replyAmber L Bahorik, Christina E Newhill, Courtney C Queen, et al.
Cancer Research|January 15, 1991
A recombinant, membrane-acting immunotoxinA Chovnick, W P Schneider, J Y Tso, et al.
Journal of Pharmaceutics|November 12, 2015
Biological Atomic Force Microscopy for Imaging Gold-Labeled Liposomes on Human Coronary Artery Endothelial CellsAna-María Zaske, Delia Danila, Michael C Queen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
The integrity of the ball-and-socket joint between V and C domains is essential for complete activity of a humanized antibodyN F Landolfi, A B Thakur, H Fu, et al.
International Journal of Cancer|June 15, 1994
Anti-Tac(Fab)-PE40, a recombinant double-chain immunotoxin which kills interleukin-2-receptor-bearing cells and induces complete remission in an in vivo tumor modelR J Kreitman, C N Chang, D V Hudson, et al.
Nature|June 1, 1989
A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxinV K Chaudhary, C Queen, R P Junghans, et al.
The Journal of Experimental Medicine|October 1, 1992
Engineered humanized dimeric forms of IgG are more effective antibodiesP C Caron, W Laird, M S Co, et al.
Cancer Research|March 1, 1990
Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disordersR P Junghans, T A Waldmann, N F Landolfi, et al.
Cancer Research|December 15, 1992
Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodiesP C Caron, M S Co, M K Bull, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Psychological Medicine|April 5, 2013
Under-reporting of drug use among individuals with schizophrenia: prevalence and predictorsA L Bahorik, C E Newhill, C C Queen, et al.
Psychological Medicine|February 14, 2014
Letter to the editor: Critique of Bahorik et al. (2013)--'Underreporting of drug use among individuals with schizophrenia: prevalence and predictors'--a replyAmber L Bahorik, Christina E Newhill, Courtney C Queen, et al.
Cancer Research|January 15, 1991
A recombinant, membrane-acting immunotoxinA Chovnick, W P Schneider, J Y Tso, et al.
Journal of Pharmaceutics|November 12, 2015
Biological Atomic Force Microscopy for Imaging Gold-Labeled Liposomes on Human Coronary Artery Endothelial CellsAna-María Zaske, Delia Danila, Michael C Queen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
The integrity of the ball-and-socket joint between V and C domains is essential for complete activity of a humanized antibodyN F Landolfi, A B Thakur, H Fu, et al.
International Journal of Cancer|June 15, 1994
Anti-Tac(Fab)-PE40, a recombinant double-chain immunotoxin which kills interleukin-2-receptor-bearing cells and induces complete remission in an in vivo tumor modelR J Kreitman, C N Chang, D V Hudson, et al.
Nature|June 1, 1989
A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxinV K Chaudhary, C Queen, R P Junghans, et al.
The Journal of Experimental Medicine|October 1, 1992
Engineered humanized dimeric forms of IgG are more effective antibodiesP C Caron, W Laird, M S Co, et al.
Cancer Research|March 1, 1990
Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disordersR P Junghans, T A Waldmann, N F Landolfi, et al.
Cancer Research|December 15, 1992
Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodiesP C Caron, M S Co, M K Bull, et al.
Pageof 6